NurExone Non Current Liabilities Total from 2010 to 2024
| NRX Stock | 0.70 0.04 5.41% |
Non Current Liabilities Total | First Reported 2010-12-31 | Previous Quarter 73 K | Current Value 71.9 K | Quarterly Volatility 22.1 K |
Check NurExone Biologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NurExone Biologic's main balance sheet or income statement drivers, such as Net Interest Income of 44.1 K, Interest Expense of 2.9 K or Selling General Administrative of 2.7 M, as well as many indicators such as . NurExone financial statements analysis is a perfect complement when working with NurExone Biologic Valuation or Volatility modules.
NurExone |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NurExone Stock Analysis
When running NurExone Biologic's price analysis, check to measure NurExone Biologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NurExone Biologic is operating at the current time. Most of NurExone Biologic's value examination focuses on studying past and present price action to predict the probability of NurExone Biologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NurExone Biologic's price. Additionally, you may evaluate how the addition of NurExone Biologic to your portfolios can decrease your overall portfolio volatility.